Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19-Reference-Cited by-同舟云学术

Effectiveness of the BNT162b2 Vaccine after Recovery from Covid-19

Published:2022-03-31 Issue:13 Volume:386 Page:1221-1229
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Hammerman Ariel¹^ORCID,Sergienko Ruslan¹,Friger Michael¹,Beckenstein Tanya¹,Peretz Alon¹,Netzer Doron¹,Yaron Shlomit¹,Arbel Ronen¹^ORCID

Affiliation:

1. From the Division of Community Medical Services, Clalit Health Services, Tel Aviv (A.H., T.B., A.P., D.N., S.Y., R.A.), the Faculty of Health Sciences, Ben Gurion University of the Negev, Beersheba (R.S., M.F.), and the Maximizing Health Outcomes Research Lab, Sapir College, Sderot (R.A.) — all in Israel.

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2119497

Reference20 articles.

1. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

2. SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy

3. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

4. Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy

5. Audio Interview: What’s Gone Right in Our Battle against Covid-19

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 vaccine uptake in a predominantly minoritized cohort hospitalized during the early pandemic in New York City;Vaccine;2024-12

2. Choosing Wisely in oncology: are guidelines effective at preventing unnecessary diagnostics? The example of surveillance positron emission tomography for patients with localised colorectal cancer;BMJ Oncology;2024-08

3. Tailoring COVID-19 Vaccination Strategies in High-Seroprevalence Settings: Insights from Ethiopia;Vaccines;2024-07-05

4. The association between BNT162b2 vaccinations and incidence of immune-mediated comorbidities;Vaccine;2024-07

5. Factors associated with childhood non-vaccination against COVID-19 in Canada: A national survey analysis;Vaccine: X;2024-06